These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27867015)

  • 1. CMTM3 decreases EGFR expression and EGF-mediated tumorigenicity by promoting Rab5 activity in gastric cancer.
    Yuan W; Liu B; Wang X; Li T; Xue H; Mo X; Yang S; Ding S; Han W
    Cancer Lett; 2017 Feb; 386():77-86. PubMed ID: 27867015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of CMTM3 promotes metastasis of gastric cancer via the STAT3/Twist1/EMT signaling pathway.
    Yuan W; Li T; Mo X; Wang X; Liu B; Wang W; Su Y; Xu L; Han W
    Oncotarget; 2016 May; 7(20):29507-19. PubMed ID: 27121055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions.
    Chrifi I; Louzao-Martinez L; Brandt M; van Dijk CGM; Burgisser P; Zhu C; Kros JM; Duncker DJ; Cheng C
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1098-1114. PubMed ID: 28428220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CMTM7 knockdown increases tumorigenicity of human non-small cell lung cancer cells and EGFR-AKT signaling by reducing Rab5 activation.
    Liu B; Su Y; Li T; Yuan W; Mo X; Li H; He Q; Ma D; Han W
    Oncotarget; 2015 Dec; 6(38):41092-107. PubMed ID: 26528697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-135b-5p promotes gastric cancer progression by targeting CMTM3.
    Lu M; Huang Y; Sun W; Li P; Li L; Li L
    Int J Oncol; 2018 Feb; 52(2):589-598. PubMed ID: 29345297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CMTM3 inhibits cell migration and invasion and correlates with favorable prognosis in gastric cancer.
    Su Y; Lin Y; Zhang L; Liu B; Yuan W; Mo X; Wang X; Li H; Xing X; Cheng X; Dong B; Hu Y; Du H; Zhu Y; Ding N; Li J; Liu W; Ma Y; Qiu X; Ji J; Han W
    Cancer Sci; 2014 Jan; 105(1):26-34. PubMed ID: 24131472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
    Zhang H; Zhang J; Nan X; Li X; Qu J; Hong Y; Sun L; Chen Y; Li T
    Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CMTM3 is reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells.
    Hu F; Yuan W; Wang X; Sheng Z; Yuan Y; Qin C; He C; Xu T
    Clin Transl Oncol; 2015 Aug; 17(8):632-9. PubMed ID: 25990505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor and membrane trafficking. EGF receptor activation of endocytosis requires Rab5a.
    Barbieri MA; Roberts RL; Gumusboga A; Highfield H; Alvarez-Dominguez C; Wells A; Stahl PD
    J Cell Biol; 2000 Oct; 151(3):539-50. PubMed ID: 11062256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engagement of the small GTPase Rab31 protein and its effector, early endosome antigen 1, is important for trafficking of the ligand-bound epidermal growth factor receptor from the early to the late endosome.
    Chua CE; Tang BL
    J Biol Chem; 2014 May; 289(18):12375-89. PubMed ID: 24644286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of dominant negative rab5 in HeLa cells regulates endocytic trafficking distal from the plasma membrane.
    Dinneen JL; Ceresa BP
    Exp Cell Res; 2004 Apr; 294(2):509-22. PubMed ID: 15023538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Knockdown of CMTM3 promotes migration and invasion of PC3 cell in vitro].
    Hu FZ; Yuan WQ; Wang XL; Qin CP; Sheng ZZ; DU YQ; Yin HQ; Xu T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):594-597. PubMed ID: 29263495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for sorting nexin 2 in epidermal growth factor receptor down-regulation: evidence for distinct functions of sorting nexin 1 and 2 in protein trafficking.
    Gullapalli A; Garrett TA; Paing MM; Griffin CT; Yang Y; Trejo J
    Mol Biol Cell; 2004 May; 15(5):2143-55. PubMed ID: 14978220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD24 associates with EGFR and supports EGF/EGFR signaling via RhoA in gastric cancer cells.
    Deng W; Gu L; Li X; Zheng J; Zhang Y; Duan B; Cui J; Dong J; Du J
    J Transl Med; 2016 Feb; 14():32. PubMed ID: 26830684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of intracellular trafficking of the EGF receptor by Rab5 in the absence of phosphatidylinositol 3-kinase activity.
    Chen X; Wang Z
    EMBO Rep; 2001 Jan; 2(1):68-74. PubMed ID: 11252727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CMTM3 suppresses chordoma progress through EGFR/STAT3 regulated EMT and TP53 signaling pathway.
    Yuan W; Wei F; Ouyang H; Ren X; Hang J; Mo X; Liu Z
    Cancer Cell Int; 2021 Sep; 21(1):510. PubMed ID: 34560882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
    Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
    Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CMTM7 as a novel molecule of ATG14L-Beclin1-VPS34 complex enhances autophagy by Rab5 to regulate tumorigenicity.
    Liu B; Lu Y; Zhang T; Yu X; Wang Q; Chi Y; Jin S; Cheng G
    Cell Commun Signal; 2021 Jul; 19(1):77. PubMed ID: 34281589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research Advances in CKLFSF-like MARVEL Transmembrane Domain Containing Member 3.
    Hu FZ; Sheng ZZ; Qin CP; Xu T
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Jun; 38(3):360-3. PubMed ID: 27469927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CKLF-Like MARVEL Transmembrane Domain-Containing Member 3 (CMTM3) Inhibits the Proliferation and Tumorigenisis in Hepatocellular Carcinoma Cells.
    Li W; Zhang S
    Oncol Res; 2017 Jan; 25(2):285-293. PubMed ID: 27629543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.